Furthermore, in RA patients, Dkk-1 and PTH serum levels are significantly higher, despite therapy with glucocorticoid (GC), tumor necrosis factor-alfa inhibitors (TNFi) or bisphosphonates (BPs) (32). Here, PTH is linked to rheumatoid arthritis.